Medtronic plc
95.41USD
-1.1800 (-1.22%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MDT.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.33▼ | $1.35 | 1 | 1 |
| Next quarter | $1.42▼ | $1.43 | 0 | 2 |
| Current year | $5.98▲ | $5.95 | 2 | 2 |
| Next year | $6.41▲ | $6.4 | 4 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $1.39 | $1.45 | +0.06 (+4.5%) |
| 2026-04-30 | $1.54 | $1.55 | +0.01 (+0.6%) |
| 2026-01-31 | $1.34 | $1.36 | +0.02 (+1.9%) |
| 2025-10-31 | $1.31 | $1.36 | +0.05 (+3.5%) |
420 ratings from 44 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $100 $99 | Oct 12, 2026 |
| Barclays | Initiated | Equal-Weight | $95 | Oct 7, 2026 |
| TD Cowen | Reiterated | Buy | $110 | Sep 30, 2026 |
| UBS | Maintained | Buy | $100 $110 | Sep 3, 2026 |
| Truist Securities | Reiterated | Hold | $86 $99 | Sep 2, 2026 |
| Wells Fargo | Maintained | Overweight | $102 $104 | Sep 2, 2026 |
| RBC Capital | Reiterated | Outperform | $118 | Sep 2, 2026 |
| B of A Securities | Maintained | Buy | $95 $110 | Sep 2, 2026 |
| Stifel | Maintained | Hold | $80 $95 | Sep 2, 2026 |
| Baird | Maintained | Neutral | $91 $100 | Sep 2, 2026 |
| BTIG | Maintained | Buy | $91 $100 | Sep 1, 2026 |
| Needham | Reiterated | Buy | $114 | Sep 1, 2026 |
| TD Cowen | Maintained | Buy | $100 $110 | Aug 28, 2026 |
| Needham | Maintained | Buy | $101 $114 | Aug 27, 2026 |
| BTIG | Reiterated | Buy | $91 | Aug 18, 2026 |
| UBS | Upgraded from Neutral | Buy | $85 $100 | Jul 28, 2026 |
| TD Cowen | Maintained | Buy | $119 $100 | Jul 10, 2026 |
| Evercore ISI Group | Maintained | Outperform | $106 $105 | Jul 6, 2026 |
| Needham | Reiterated | Buy | $101 | Jun 17, 2026 |
| Goldman Sachs | Maintained | Neutral | $84 $83 | Jun 5, 2026 |
| Bernstein | Maintained | Outperform | $112 $97 | Jun 5, 2026 |
| UBS | Maintained | Neutral | $90 $85 | Jun 4, 2026 |
| TD Cowen | Reiterated | Buy | $119 | Jun 4, 2026 |
| RBC Capital | Reiterated | Outperform | $118 | Jun 4, 2026 |
| Wells Fargo | Maintained | Overweight | $114 $102 | Jun 4, 2026 |
77 filings from 27 insiders · 27 buy / 3 sell over 6m
Officers and directors of MDT, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Lofton Kevin EDirector | Other | 182 | — | — | Oct 15, 2026 |
| Marinaro MichaelOfficer, EVP, Pres MedSurg and Americas | Sell | 10.4k | $96.00 | $1.00M | Oct 15, 2026 |
| Martha GeoffreyDirector; Officer, Chairman and CEO | Sell | 50.0k | $95.00 | $4.75M | Oct 15, 2026 |
| KIIL HARRY SKIPOfficer, EVP & President Cardiovascular | Sell | 1.5k | $93.65 | $139k | Sep 16, 2026 |
| Blomquist Denise L.Officer, Chief Accounting Officer | Gift | 600 | — | — | Sep 15, 2026 |
| THOMPSON KWELIOfficer | Grant | 6.9k | — | — | Aug 3, 2026 |
| MARTHA GEOFFREY SChief Executive Officer | Grant | 41.5k | — | — | Aug 3, 2026 |
| QUINN MICHELLEGeneral Counsel | Grant | 6.3k | — | — | Aug 3, 2026 |
| MARINARO MICHAELOfficer | Grant | 57.1k | — | — | Aug 3, 2026 |
| WALTER MATTHEW R.Officer | Grant | 5.8k | — | — | Aug 3, 2026 |
| PIETON THIERRY JEAN LOUISChief Financial Officer | Grant | 11.5k | — | — | Aug 3, 2026 |
| BLOMQUIST DENISE LOfficer | Grant | 2.3k | — | — | Aug 3, 2026 |
| KIIL HARRY SKIPOfficer | Grant | 9.2k | — | — | Aug 3, 2026 |
| WALTER MATTHEW R.Officer | Sell | 3.1k | $83.15 | $258k | Jul 8, 2026 |
| KIIL HARRY SKIPOfficer | Sell | 4.2k | $80.44 | $337k | Jun 8, 2026 |
| MARINARO MICHAELOfficer | Other | 19.0k | — | — | May 26, 2026 |
| WALTER MATTHEW R.Officer | Other | 9.1k | — | — | May 26, 2026 |
| BLOMQUIST DENISE LOfficer | Other | 1.7k | — | — | May 26, 2026 |
| WALL BRETT AOfficer | Other | 26.9k | — | — | May 26, 2026 |
| MARTHA GEOFFREY SChief Executive Officer | Other | 95.0k | — | — | May 26, 2026 |
No analyst notes on MDT yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 17 | 10 | 0 | 0 | Buy2.23 |
| 1 mo ago | 3 | 16 | 9 | 0 | 0 | Buy2.21 |
| 2 mo ago | 3 | 17 | 9 | 0 | 0 | Buy2.21 |
| 3 mo ago | 3 | 16 | 10 | 0 | 0 | Buy2.24 |
Members whose judged calls on MDT have played out most reliably.
No settled calls on MDT yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice